Publications 2020

Freidl, R., Gstottner, A., Baranyi, U., Swoboda, I., Stolz, F., Focke-Tejkl, M., Wekerle, T., van Ree, R., Valenta, R., Linhart, B. 2020. Resistance of parvalbumin to gastrointestinal digestion is required for profound and long-lasting prophylactic oral tolerance. Allergy;75(2):326-35.

Mahr, B., Pilat, N., Granofszky, N., Muckenhuber, M., Unger, L. W., Weijler, A. M., Wiletel, M., Steiner, R., Dorner, L., Regele, H., Wekerle, T. 2020. Distinct roles for major and minor antigen barriers in chimerism-based tolerance under irradiation-free conditions. Am J Transplant:10.

Weijler, A. M., Mucha, J., Farkas, A. M., Baranyi, U., Pilat, N., Cho, A., Muckenhuber, M., Hopf, S., Wahrmann, M., Linhart, B., Valenta, R. and Wekerle, T. 2020. Methods to Detect MHC-Specific IgE in Mice and Men. Front Immunol;11:586856; 10.3389/fimmu.2020.586856

Oberbauer, R., Edinger, M., Berlakovich, G., Kalhs, P., Worel, N., Heinze, G., Wolz, M., Lion, T. and Wekerle, T. 2020. A prospective controlled trial to evaluate safety and efficacy of in vitro expanded recipient regulatory T cell therapy and tocilizumab together with donor bone marrow infusion in HLA-mismatched living donor kidney transplant recipients (Trex001). Frontiers of Medicine accepted;

Schwarz, C. and Wekerle, T. 2020. Regulatory Cell Therapy in Kidney Transplantation: Promise Not Yet Fulfilled. Transplantation;104(11):2262-3; 10.1097/TP.0000000000003150.